Fund profile
MBX Capital
New York, United States
Leading
About
MBX Capital, established in 2015, is a venture capital firm headquartered in Claymont, Delaware. The firm specializes in early-stage investments within the healthcare and life sciences sectors, focusing on pre-seed, seed, and Series A rounds. MBX Capital has a robust portfolio that includes companies like Luna, Concert Health, Koneksa Health, Atlas Labs, and Buoy Health. Notable recent investments by MBX Capital include Vivodyne, which raised $38 million in November 2023, and Macro Trials, which secured $6 million in June 2023. These investments underline the firm's commitment to advancing biotechnology and clinical trials (PitchBook). Additionally, MBX Capital led a $10.7 million Series A financing for Contraline, supporting the development of innovative medical technologies. The firm's co-founders, Gurdane Bhutani and Zeshan Muhammedi, lead a team that provides hands-on support to portfolio companies, leveraging their expertise and extensive network to drive growth and innovation. MBX Capital's strategic approach and active involvement make it a key player in the venture capital landscape for healthcare and life sciences startups.
Details
Highlights
$3.2M
Historical average check
$38M
Historical max check
June 2024
Last investment date
42
Investments
Biotech
Healthtech & Wellness
Pharma
Lifestyle
Showing 0 lists